Cell & Gene Therapy equipment selection starts with sterile workflow fit. Learn how to compare contamination control, automation, GMP readiness, and scale-up factors with confidence.

Digital chronic disease management takes center stage at Hospitalar 2026—discover how ANVISA’s new certification rules reshape market access for biosafety cabinets, centrifuges, and remote diagnostics in Latin America.

EU-Mexico Pact speeds Bio-Safety Cabinet certifications—cutting 4–8 weeks off CE + COFEPRIS approval for Class II/III BSCs. Act now to leverage mutual recognition.

HEPA filter shortage hits global labs: Class II/III bio-safety cabinet lead times now 12–14 weeks. Act now to secure inventory, avoid delays in life sciences & pharma projects.

HEPA filter shortage drives biosafety cabinet lead times to 10–12 weeks—impacting labs, pharma & biocontainment. Act now to secure supply and avoid project delays.

Cell & Gene Therapy equipment guide for lab expansion: compare biosafety, automation, compliance, and scalability specs to reduce risk, improve throughput, and choose with confidence.

China's 2026 Green Design Guidelines impact biopharma equipment exports—learn how new carbon, RoHS & LCA rules affect your EU, SEA & RCEP shipments.

Biosafety equipment checks before daily operation help labs prevent contamination, protect staff, and stay compliant. Discover a practical pre-use routine to improve safety, quality, and workflow reliability.